Article
September 9, 2024
Mucke, director of the Gladstone Institute of Neurological Disease, discusses what's next for Alzheimer’s research, the role of nonprofit research in developing new therapies, and why he's more hopeful than ever for a future where neurodegenerative diseases are fully treatable—and even preventable.
Alzheimer’s Disease
Neurological Disease
Mucke Lab
Aging
Gladstone in the News
September 6, 2024
University of San Francisco—Students in the Master’s in Biotechnology program at the University of San Francisco visited Gladstone to learn about industry-altering scientific breakthroughs and met with Benoit Bruneany, director of the Gladstone Institute of Cardiovascular Disease, and Stephen Freedman, vice president of corporate liaison and ventures.
Gladstone Experts
Gladstone in the News
September 6, 2024
Genetic Engineering & Biotechnology News—Gladstone Investigator Seth Shipman and his team developed a new technology using retrons to engineer bacteria-fighting viruses known as phages, which could be used to kill antibiotic-resistant bacteria.
Gladstone Experts
Shipman Lab
Article
September 5, 2024
The $350 million Gladstone NOW campaign will raise funds to expand Gladstone’s footprint, hire hundreds of additional scientists, and seize emerging opportunities for high-impact biomedical research that can overcome disease.
Philanthropy
Institutional News
News Release
Gladstone in the News
August 29, 2024
Inside Precision Medicine—A new study by Gladstone Senior Investigators Katerina Akassoglou and Warner Greene shows that fibrin, a blood coagulation protein, drives the cascade of symptoms that are the hallmarks of infection by the SARS-CoV-2 virus.
Gladstone Experts
COVID-19
Akassoglou Lab
Gladstone in the News
August 28, 2024
Chemical & Engineering News—In a new study, scientists in Jennifer Doudna’s lab probe how viruses interfere with host signaling. Postdoctoral Fellow Jason Nomburg explains how they assembled a database of predicted structures of viral proteins, and used it to find the functions of previously mysterious proteins.
Gladstone Experts
Virology
Doudna Lab
Gladstone in the News
August 27, 2024
The Voice of San Francisco—Melanie Ott, director of the Gladstone Institute of Virology, answers questions about mpox at a time when many people are wondering about the virus’s ability to become another global pandemic, and also talks about how she and her team are contributing to the fight against it.
Gladstone Experts
Virology
Ott Lab